Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

118.84 -4.56 (-3.70%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,069,915
Open 123.89
Bid (Size) 118.60 (100)
Ask (Size) 119.25 (200)
Prev. Close 123.40
Today's Range 117.54 - 124.00
52wk Range 86.08 - 124.61
Shares Outstanding 1,253,809,440
Dividend Yield 2.66%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's session: S&P500 movers
Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Gilead's Trodelvy Misses Main Goal In Breast Cancer Study But Shows Early Survival Trend
Gilead's Trodelvy missed a key goal in breast cancer, while Livdelzi showed durable efficacy and safety in long-term liver disease studies. 
Via Benzinga

Performance

YTD
+29.3%
+29.3%
1 Month
+0.5%
+0.5%
3 Month
-0.5%
-0.5%
6 Month
+22.6%
+22.6%
1 Year
+21.4%
+21.4%

More News

Read More
Gilead Provides Update on Phase 3 ASCENT-07 Study
From Gilead Sciences, Inc.
Via Business Wire
Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow Disease Progression
From Gilead Sciences, Inc.
Via Business Wire
Navigating the Volatility: Q3 2025 Earnings Season Delivers Both Cheers and Concerns
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
Via MarketMinute
Topics Intellectual Property
Gilead Sciences’s Q3 Earnings Call: Our Top 5 Analyst Questions
Via StockStory
Topics Earnings
3 Cash-Rich Stocks With High Growth Potential Right Now
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Gilead Sciences Inc (NASDAQ:GILD) Appears as a Decent Value Stock
Via Chartmill
Moderna Earnings: What To Look For From MRNA
Via StockStory
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
Via TokenRing AI
Topics Artificial Intelligence
Gilead Sciences to Present at Upcoming Investor Conferences
From Gilead Sciences, Inc.
Via Business Wire
Gilead and Kite Showcase Continued Progress in Transforming Blood Cancer Care With New Cell Therapy Data at ASH 2025
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences Inc (NASDAQ:GILD): A Dividend Stock with a Secure Payout and Strong Fundamentals
Via Chartmill
Amgen Earnings: What To Look For From AMGN
Via StockStory
Topics Artificial Intelligence
What To Expect From Myriad Genetics’s (MYGN) Q3 Earnings
Via StockStory
Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect
Via StockStory
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Via MarketMinute
Topics Intellectual Property
Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026
Via Benzinga
Topics Earnings
Gilead GILD Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
Via Benzinga
GILD Q3 Deep Dive: HIV and Liver Disease Strength Offset Oncology Headwinds
Via StockStory
Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product With Yeztugo® (Lenacapavir)
From Gilead Sciences, Inc.
Via Business Wire
Meta Meltdown Sends Nasdaq Tumbling as Apple Shines After Hours
Via Chartmill
Topics Economy

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 118.84
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 11/07/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 149.00B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 149B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.